DS
ASND icon

David Shaw’s Ascendis Pharma A/S ASND Stock Holding History

David Shaw’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-8,000
Closed -$1.27M – 5379
2021
Q3 		$1.27M Hold
8,000
– – ﹤0.01% 3407
2021
Q2 		$1.05M Hold
8,000
– – ﹤0.01% 3489
2021
Q1 		$1.03M Buy
+8,000
New +$1.22M ﹤0.01% 3083

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

David Shaw's ASND Position: Q2 2026 in Review

David Shaw increased its Ascendis Pharma A/S (ASND) stake by 2,808% in Q2 2026, buying an estimated $6.97M and bringing the position to 30,883 shares worth $8.24M. The position accounts for ﹤0.01% of the portfolio, ranked #1993.

David Shaw first reported a position in ASND in Q1 2018 and has held it in 34 quarters since. The position peaked at $51.4M in Q1 2024. 311 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

  • David Shaw held 30,883 shares of Ascendis Pharma A/S worth $8.24M as of Q2 2026.
  • David Shaw bought 29,821 Ascendis Pharma A/S shares in Q2 2026, an estimated $6.97M.
  • Ascendis Pharma A/S made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #1993 holding.
  • David Shaw first reported a position in Ascendis Pharma A/S in Q1 2018 and has held it in 34 quarters since.
  • David Shaw's Ascendis Pharma A/S position peaked at $51.4M in Q1 2024.
  • 311 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.